文献速递眼整形与眼眶

SOX9通过MAPK/ERK1/2通路诱导甲状腺眼病眼眶成纤维细胞活化

SOX9 Induces Orbital Fibroblast Activation in Thyroid Eye Disease Via MAPK/ERK1/2 Pathway.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

该研究评估了甲状腺眼病(TED)患者眼眶成纤维细胞(OFs)中SOX9的表达及其在眼眶纤维化中的潜在作用与机制。TED-OFs中SOX9 mRNA和蛋白水平显著高于健康对照,SOX9敲低可下调细胞外基质相关基因并抑制收缩和抗凋亡能力,过表达则增强转化、迁移和增殖能力。SOX9通过MAPK/ERK1/2通路活化OFs,EGFR为其下游靶基因,SOX9/EGFR可被认为是TED眼眶纤维化的治疗靶点。

要点

  • TED患者OFs中SOX9 mRNA和蛋白水平显著高于健康对照。
  • SOX9敲低下调细胞外基质相关基因,过表达则上调这些基因。
  • SOX9敲低抑制磷酸化ERK1/2表达,过表达则起相反作用。

核心结论

  • TED-OFs中SOX9高表达,SOX9可通过MAPK/ERK1/2信号通路活化OFs,进而促进OFs增殖和分化。
  • EGFR是SOX9的下游靶基因,SOX9/EGFR可被认为是TED眼眶纤维化的治疗靶点。

研究设计与样本

  • 实验研究,从TED患者(n=10)和健康对照(n=6)的眼眶结缔组织培养OFs。
  • 通过小干扰RNA敲低SOX9或通过慢病毒转导过表达SOX9,采用胶原凝胶收缩实验检测收缩活性、EdU实验检测增殖、RNA测序评估转录组变化。

主要发现

  • TED患者OFs中SOX9 mRNA和蛋白水平显著高于健康对照。
  • SOX9敲低下调细胞外基质相关基因,SOX9过表达上调这些基因。
  • SOX9敲低显著降低OFs的收缩和抗凋亡能力,SOX9过表达增强OFs的转化、迁移和增殖能力。
  • SOX9敲低抑制磷酸化ERK1/2表达,SOX9过表达则起相反作用。
  • RNA测序筛选出EGFR为显著下调基因之一,染色质免疫沉淀-qPCR证实SOX9结合于EGFR启动子。

临床怎么用

  • 作者认为SOX9/EGFR可被认为是治疗TED眼眶纤维化的靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the expression of sry-box transcription factor 9 (SOX9) in orbital fibroblasts (OFs) of thyroid eye disease (TED) and to find its potential role and underlying mechanism in orbital fibrosis. METHODS: OFs were cultured from orbital connective tissues obtained from patients with TED (n = 10) and healthy controls (n = 6). SOX9 was depleted by small interfering RNA or overexpressed through lentivirus transduction in OFs. Fibroblast contractile activity was measured by collagen gel contraction assay and proliferation was examined by EdU assay. Transcriptomic changes were assessed by RNA sequencing. RESULTS: The mRNA and protein levels of SOX9 were significantly higher in OFs cultured from patients with TED than those from healthy controls. Extracellular matrix-related genes were down-regulated by SOX9 knockdown and up-regulated by SOX9 overexpression in TED-OFs. SOX9 knockdown significantly decrease the contraction and the antiapoptotic ability of OFs, whereas the overexpression of SOX9 increased the ability of transformation, migration, and proliferation of OFs. SOX9 knockdown suppressed the expression of phosphorylated ERK1/2, whereas its overexpression showed the opposite effect. Epidermal growth factor receptor (EGFR) is one of the notably down-regulated genes screened out by RNA sequencing. Chromatin immunoprecipitation-qPCR demonstrated SOX9 binding to the EGFR promoter. CONCLUSIONS: A high expression of SOX9 was found in TED-OFs. SOX9 can activate OFs via MAPK/ERK1/2 signaling pathway, which in turn promotes proliferation and differentiation of OFs. EGFR was a downstream target gene of SOX9. SOX9/EGFR can be considered as therapeutic targets for the treatment of orbital fibrosis in TED.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhou M, Lin B, Wu P, et al. SOX9 Induces Orbital Fibroblast Activation in Thyroid Eye Disease Via MAPK/ERK1/2 Pathway. Invest Ophthalmol Vis Sci. 2024. PMID: 38345552. doi:10.1167/iovs.65.2.25

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。